Media Advisory: Medco CEO David B. Snow Jr. To Address American Enterprise Institute: ‘Health IT: Empowering Precision Medicine’

WASHINGTON, March 16 /PRNewswire-FirstCall/ — Medco Health Solutions, Inc. (NYSE: MHS) Chairman and CEO David B. Snow Jr. is scheduled to deliver the Keynote Luncheon Address to the American Enterprise Institute’s health care conference entitled, “Can Health IT Improve Care?” on Wednesday, March 18, 2009, at 12:30 p.m.

Through the stimulus package, $19 billion of new federal funding will be directed at expanding the use of health information technology. Snow will articulate a compelling plan that leverages this investment to set our nation on a path to comprehensive, workable health care reform — empowering a new generation of precision medicine. With more than 30 years experience in the health care industry, Snow is an innovative and provocative thought leader whose candid views on health reform have generated deep interest in Washington and beyond.

    WHO:     Medco Chairman and CEO David B. Snow Jr.

    WHAT:    Address before American Enterprise Institute (AEI):
             "Health IT: Empowering Precision Medicine"

    WHEN:    Wednesday, March 18, 2009 @ 12:30 p.m.

    WHERE:   American Enterprise Institute
             Wohlstetter Conference Center, 12th Floor
             1150 Seventeenth Street NW
             Washington, DC 20036

    RSVP:    Media attendees are required to register for this event.
             Please contact Sara Huneke at AEI:
             sara.huneke@aei.org or (202) 862-4870

About Medco

Medco Health Solutions, Inc (NYSE: MHS) is a leading health care company, serving the needs of more than 60 million people. Medco, the world’s most advanced pharmacy(R), provides clinically driven pharmacy services designed to improve the quality of care and lower total health care costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. Through its unique Medco Therapeutic Resource Centers(R) and the Accredo Health Group, Medco’s Specialty Pharmacy, the company is creating innovative models for the care of patients with chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy — a key element in reforming America’s health care system. Medco is ranked number 51 on the Fortune 500 list, with 2008 revenues of more than $51 billion. For more information about Medco, go to http://www.medcohealth.com.

This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.

SOURCE Medco Health Solutions, Inc.